The Lancet Group

The Lancet Rheumatology in conversation with

Join The Lancet Rheumatology editors as they chat with authors about recent studies and their significance for health, policy, and various medical issues.

Listen on Apple Podcasts

Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy

21 mins • Jun 3, 2025

Recent Episodes

Jun 3, 2025

Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy

21 mins

Apr 25, 2025

Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus

26 mins

Mar 24, 2025

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

19 mins

Feb 24, 2025

Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

9 mins

Jan 27, 2025

Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia

19 mins

Language
English
Country
United Kingdom
Feed Host
Request an Update
Updates may take a few minutes.